
    
      This study is a prospective, single-centre, open, randomised study to improve management of
      acute COPD exacerbation within the Emergency Department. Adults with severe COPD are
      randomised into 2 groups: vibrating mesh nebuliser or standard jet nebuliser treatment.
      Salbutamol (5mg) and Ipratropium (0.5mg) will be administered via Aerogen Ultra via valved
      mask or a standard jet nebuliser via open face mask/. Two further doses of salbutamol to be
      delivered.
    
  